Duoli Xie
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Multi-Technique Integration Identifies O-GlcNAc Transferase in Fibroblast-Like Synoviocytes as a Therapeutic Target for Rheumatoid Arthritis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2026
Design, Synthesis, and Evaluation of Nucleolin-Bridged, MDM2-Recruiting IRAK4 Degraders for the Treatment of Autoimmune Diseases.
Journal: Journal of medicinal chemistry
Published: February 09, 2026
PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapy.
Journal: Journal of hematology & oncology
Published: July 15, 2025
Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis.
Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis.
Journal: Expert reviews in molecular medicine
Published: June 05, 2025
An aptamer specifically targeting mCRP ameliorates experimental arthritis.
Journal: Journal of orthopaedic translation
Published: May 15, 2025
Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting Ability.
Journal: Journal of medicinal chemistry
Published: October 22, 2024
Development of hybrid aptamers-engineered PROTACs for degrading VEGF165 in both tumor- and vascular endothelial cells.
Journal: European journal of medicinal chemistry
Published: September 18, 2024
Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release.
Journal: Journal of translational medicine
Published: March 19, 2024
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity.
Journal: Nature communications
Published: March 16, 2024
Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: January 22, 2024
Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis.
Journal: Bone research
Published: December 13, 2023
Last Updated: 09/26/2026